Engineered Phage with Aggregation-Induced Emission Photosensitizer in Cocktail Therapy against Sepsis

© 2022 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 35(2023), 6 vom: 28. Feb., Seite e2208578
1. Verfasser: Wu, Ming-Yu (VerfasserIn)
Weitere Verfasser: Chen, Luojia, Chen, Qingrong, Hu, Rui, Xu, Xiaoyu, Wang, Yifei, Li, Jie, Feng, Shun, Dong, Changjiang, Zhang, Xiao-Lian, Li, Zhiqiang, Wang, Lianrong, Chen, Shi, Gu, Meijia
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article aggregation-induced emission phage cocktail therapy photodynamic therapy photosensitizers sepsis Photosensitizing Agents Anti-Bacterial Agents
LEADER 01000naa a22002652 4500
001 NLM349535612
003 DE-627
005 20231226042850.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202208578  |2 doi 
028 5 2 |a pubmed24n1165.xml 
035 |a (DE-627)NLM349535612 
035 |a (NLM)36440662 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Wu, Ming-Yu  |e verfasserin  |4 aut 
245 1 0 |a Engineered Phage with Aggregation-Induced Emission Photosensitizer in Cocktail Therapy against Sepsis 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 13.02.2023 
500 |a Date Revised 13.02.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2022 Wiley-VCH GmbH. 
520 |a Sepsis, a widely recognized disease, is characterized by multiple pathogen infections. Therefore, it is imperative to develop methods that can efficiently identify and neutralize pathogen species. Phage cocktail therapy utilizes the host specificity of phages to adapt to infect resistant bacteria. However, its low sterilization stability efficiency and lack of imaging units seriously restrict its application. Here, a novel strategy combining the aggregation-induced emission photosensitizer (AIE-PS) TBTCP-PMB with phages through a nucleophilic substitution reaction between benzyl bromide and sulfhydryl groups to remove pathogenic bacteria for sepsis treatment is proposed. This strategy retains the phage's host specificity while possessing AIE-PS characteristics with a fluorescence imaging function and reactive oxygen species (ROS) for detecting and sterilizing bacteria. This synergetic strategy combining phage cocktail therapy and photodynamic therapy (PDT) shows a strong "1 + 1 > 2" bactericidal efficacy and superior performance in sepsis mouse models with good biocompatibility. Furthermore, the strategy can quickly diagnose blood infections of clinical blood samples. This simple and accurate strategy provides a promising therapeutic platform for rapid pathogen detection and point-of-care diagnosis. Moreover, it presents a new method for expanding the library of antibacterial drugs to develop new strain identification and improve infectious disease treatment, thereby demonstrating strong translational potential 
650 4 |a Journal Article 
650 4 |a aggregation-induced emission 
650 4 |a phage cocktail therapy 
650 4 |a photodynamic therapy 
650 4 |a photosensitizers 
650 4 |a sepsis 
650 7 |a Photosensitizing Agents  |2 NLM 
650 7 |a Anti-Bacterial Agents  |2 NLM 
700 1 |a Chen, Luojia  |e verfasserin  |4 aut 
700 1 |a Chen, Qingrong  |e verfasserin  |4 aut 
700 1 |a Hu, Rui  |e verfasserin  |4 aut 
700 1 |a Xu, Xiaoyu  |e verfasserin  |4 aut 
700 1 |a Wang, Yifei  |e verfasserin  |4 aut 
700 1 |a Li, Jie  |e verfasserin  |4 aut 
700 1 |a Feng, Shun  |e verfasserin  |4 aut 
700 1 |a Dong, Changjiang  |e verfasserin  |4 aut 
700 1 |a Zhang, Xiao-Lian  |e verfasserin  |4 aut 
700 1 |a Li, Zhiqiang  |e verfasserin  |4 aut 
700 1 |a Wang, Lianrong  |e verfasserin  |4 aut 
700 1 |a Chen, Shi  |e verfasserin  |4 aut 
700 1 |a Gu, Meijia  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 35(2023), 6 vom: 28. Feb., Seite e2208578  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:35  |g year:2023  |g number:6  |g day:28  |g month:02  |g pages:e2208578 
856 4 0 |u http://dx.doi.org/10.1002/adma.202208578  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 35  |j 2023  |e 6  |b 28  |c 02  |h e2208578